NCT06466733View on ClinicalTrials.gov

Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA)

NANot yet recruitingINTERVENTIONAL
Enrollment

658

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

July 31, 2031

Study Completion Date

July 31, 2032

Conditions
Chronic Subdural Hematoma
Interventions
PROCEDURE

Embolization of the middle meningeal artery

Embolization of the middle meningeal artery ipsilateral to the chronic subdural hematoma is performed infusing embolic polyvinyl alcohol (PVA) microparticles.

PROCEDURE

Surgical Evacuation via burr hole or craniotomy

The standard of care for chronic subdural hematoma, burr hole or craniotomy are performed ipsilateral to the lesion.

All Listed Sponsors
lead

Juan M. Ramos Acevedo

OTHER

NCT06466733 - Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA) | Biotech Hunter | Biotech Hunter